Transgenomic, Inc. Reports First Quarter 2013 Financial Results

Published: May 09, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Transgenomic, Inc. (OTCBB: TBIO) today reported financial results for the first quarter ended March 31, 2013 and provided a business update.

First Quarter Financial Results

Net sales for the first quarter of 2013 increased by $0.2 million, or 2%, to $7.4 million compared to $7.2 million for the same period in 2012. The increase from last year’s first quarter was principally driven by an 11% increase in the Laboratory Services unit, reflecting higher test volumes from our Nuclear Mitome, ScoliScoreTM and C-GAAP diagnostic tests, as well as a modest shift toward higher priced tests. This increase was partially offset by lower sales of instruments in the Diagnostic Tools segment.

Help employers find you! Check out all the jobs and post your resume.

Back to news